PTM Therapeutics
San Carlos, USA
|
Description:
PTM Therapeutics creates and develops therapies for the treatment of chronic diseases and cancer. The company's lead product PTM-001 is a humanized glycan targeting antibody that is being developed for the treatment of Inflammatory Bowel Disease/UC.
PTM Therapeutics creates and develops therapies for the treatment of chronic diseases and cancer. The company's lead product PTM-001 is a humanized glycan targeting antibody that is being developed for the treatment of Inflammatory Bowel Disease/UC.